IL38870A - Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them - Google Patents

Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL38870A
IL38870A IL38870A IL3887072A IL38870A IL 38870 A IL38870 A IL 38870A IL 38870 A IL38870 A IL 38870A IL 3887072 A IL3887072 A IL 3887072A IL 38870 A IL38870 A IL 38870A
Authority
IL
Israel
Prior art keywords
dichlorophenoxy
butylamino
racemic
propanol
tert
Prior art date
Application number
IL38870A
Other languages
English (en)
Other versions
IL38870A0 (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL38870A0 publication Critical patent/IL38870A0/xx
Publication of IL38870A publication Critical patent/IL38870A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
IL38870A 1971-03-17 1972-03-02 Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them IL38870A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO001156 1971-03-17

Publications (2)

Publication Number Publication Date
IL38870A0 IL38870A0 (en) 1972-05-30
IL38870A true IL38870A (en) 1975-08-31

Family

ID=10996691

Family Applications (1)

Application Number Title Priority Date Filing Date
IL38870A IL38870A (en) 1971-03-17 1972-03-02 Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
JP (1) JPS5310581B1 (da)
AT (1) AT316515B (da)
AU (1) AU461159B2 (da)
BE (1) BE780719A (da)
CA (1) CA1002537A (da)
CH (1) CH569692A5 (da)
CS (1) CS163270B2 (da)
DK (1) DK133872B (da)
ES (1) ES401235A1 (da)
FI (1) FI55025C (da)
FR (1) FR2130284B1 (da)
GB (1) GB1337921A (da)
IL (1) IL38870A (da)
NL (1) NL170626C (da)
NO (1) NO134836C (da)
PL (1) PL88985B1 (da)
SE (1) SE384021B (da)
SU (1) SU496721A3 (da)
YU (1) YU35435B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172137B (hu) 1976-03-02 1978-06-28 Gyogyszerkutato Intezet Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1236523C2 (de) * 1962-02-15 1975-06-12 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Verfahren zur herstellung von basischen phenylaethern und deren salzen

Also Published As

Publication number Publication date
DE2213044B2 (de) 1977-05-26
BE780719A (fr) 1972-07-03
DE2213044A1 (de) 1972-09-28
CH569692A5 (da) 1975-11-28
JPS5310581B1 (da) 1978-04-14
AU461159B2 (en) 1975-04-29
FI55025B (fi) 1979-01-31
YU35435B (en) 1981-02-28
CA1002537A (en) 1976-12-28
NL170626C (nl) 1982-12-01
GB1337921A (en) 1973-11-21
YU63972A (en) 1980-06-30
NO134836C (da) 1976-12-21
FR2130284A1 (da) 1972-11-03
ES401235A1 (es) 1975-02-16
SU496721A3 (ru) 1975-12-25
AT316515B (de) 1974-07-10
IL38870A0 (en) 1972-05-30
NL7203323A (da) 1972-09-19
NO134836B (da) 1976-09-13
DK133872C (da) 1976-12-27
FI55025C (fi) 1979-05-10
DK133872B (da) 1976-08-02
SE384021B (sv) 1976-04-12
PL88985B1 (da) 1976-10-30
FR2130284B1 (da) 1975-10-10
NL170626B (nl) 1982-07-01
AU3965972A (en) 1973-09-13
CS163270B2 (da) 1975-08-29

Similar Documents

Publication Publication Date Title
IL40475A0 (en) Novel tetrazole derivatives,their preparation and pharmaceutical compositions containing them
YU318172A (en) Process for obtaining the novel compound 1-(2-hydroxy-4-carboxy-methoxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyll)-propane-1-one and physiologically acceptable salts thereof
IL39346A (en) 2,4-diamino-pyrimidine-5-carboxylic acid amide derivatives and herbicidal compositions containing them
PH14121A (en) 1-(4'-hydroxy-3'-aminosulfonamido-phenyl)-2-amino-ethanes and salts
IL39212A0 (en) N-(dimethylaminomethylidene)-thiol and-thiono-phosphoric acid ester imides,their preparation and their use as insecticides or acaricides
IL40412A0 (en) Substituted 3-hydroxymethyl-isoquinolines and salts thereof,their preparation and pharmaceutical compositions containing them
BE783127A (fr) Compositions, composes et procedes pour combattre les organismes nuisibles
IL44266A0 (en) Novel substituted 2-phenylamino-imidazolines-(2) and their salts,their preparation and pharmaceutical compositions containing them
ATA401872A (de) Bildmischschaltung
IL40572A (en) 4-(2'-fluoro-4-biphenylyl)-1-butanol,processes for its preparation and pharmaceutical compositions containing it
ZA725202B (en) Process for producing 4-hydroxymethyl-1-keto-1,2-dihydrophthalazine and acid salts thereof,and pharmaceutical composition containing the same
IL38870A0 (en) Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them
IL40161A0 (en) 4-(4-biphenylyl)-butyric acid amides,their preparation and pharmaceutical compositions containing them
IL38593A (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL39126A (en) 2-(2'-alkylamino-1'-hydroxyethyl)benzofuran derivatives,their preparation and pharmaceutical compositions containing them
IL41035A (en) N-lysergyl-3'-amino-pyridine derivatives,their production and pharmaceutical compositions containing them
IL39620A0 (en) Substituted phenylimidazolidinones and their salts,their preparation and pharmaceutical compositions containing them
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL36269A0 (en) Substituted aminoethanols and salts thereof,their preparation and pharmaceutical compositions containing them
GB1400842A (en) Oxaprostanoic acid derivatives and pharmaceutical compositions containing the same
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
IL36855A (en) Azobis-imidazolium salts,their preparation and pharmaceutical compositions containing them
IL40169A0 (en) New aminoalcohol esters and salts thereof,their preparation and pharmaceutical compositions containing them
PH9589A (en) 1-(l-(-)-gamma-amino-gamma-hydroxybutyryl)-kanamycin salts thereof